1999 NOV 29 - (NewsRx.com) -- Pulsing autologous mature dendritic cells (DC) with a novel RAGE-1 HLA-B7 peptide stimulated anticancer T-cell responses in patients with renal cell carcinoma (RCC).
E. Ranieri and colleagues from institutions in Italy and Pennsylvania, USA, sought to promote RCC specific T-cell responses against the novel tumor antigen RAGE-1 epitopes using a DC-based immunization strategy in patients with RCC. The results of their study were presented at the 32nd Annual Meeting of the American Society of Nephrology, held November 1-8, 1999, in Miami Beach, Florida.
"RCC is the most prevalent form of malignancy of the kidney and is among a small …

Комментариев нет:
Отправить комментарий